Midway Immunology and Research Center ( Site 5657) — Ft. Pierce, Florida

Public research footprint of Midway Immunology and Research Center ( Site 5657), compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

HIV-1-infection · Human Immuno-deficiency Virus (HIV) Disease · HIV Pre-exposure Prophylaxis · Hepatitis C Virus (HCV)

Recently updated registry entries

NCT07682961 — Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in… (Recruiting)
NCT07266831 — A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been… (Recruiting)
NCT07645287 — A Study of GS-3242 in Combination With Lenacapavir Versus Biktarvy in Virologically… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Midway Immunology and Research Center ( Site 5657)?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.